Elise Aasebø

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Acute Myeloid Leukemia

Cell Cycle Arrest

Mesenchymal Stem Cells

Prognostic Factors

Top Venues

International journal of molecular sciences

Journal of clinical medicine

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Frode Selheim, Elise Aasebø, Håkon Reikvam, Øystein Bruserud, Maria Hernandez-Valladares
Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations. International journal of molecular sciences 25 (10) (2024)
Frode Selheim, Elise Aasebø, Håkon Reikvam, Øystein Bruserud, Maria Hernandez-Valladares
Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations. International journal of molecular sciences 25 (10) (2024)
Frode Selheim, Elise Aasebø, Håkon Reikvam, Øystein Bruserud, Maria Hernandez-Valladares
Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations. International journal of molecular sciences 25 (10) (2024)
Sushma Bartaula-Brevik, Calum Leitch, Maria Hernandez-Valladares, Elise Aasebø, Frode S Berven, Frode Selheim, Annette K Brenner, Kristin Paulsen Rye, Marie Hagen, Håkon Reikvam, Emmet Mc Cormack, Øystein Bruserud, Tor Henrik Anderson Tvedt
Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. Journal of clinical medicine 12 (17) (2023)
Frode Selheim, Elise Aasebø, Øystein Bruserud, Maria Hernandez-Valladares
High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5. Cancers 16 (1) (2023)
Frode Selheim, Elise Aasebø, Øystein Bruserud, Maria Hernandez-Valladares
High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5. Cancers 16 (1) (2023)
Elise Aasebø, Annette K Brenner, Even Birkeland, Tor Henrik Anderson Tvedt, Frode Selheim, Frode S Berven, Øystein Bruserud
The Constitutive Extracellular Protein Release by Acute Myeloid Leukemia Cells-A Proteomic Study of Patient Heterogeneity and Its Modulation by Mesenchymal Stromal Cells. Cancers 13 (7) (2021)
Maria Hernandez-Valladares, Rebecca Wangen, Elise Aasebø, Håkon Reikvam, Frode S Berven, Frode Selheim, Øystein Bruserud
Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid. Cancers 13 (9) (2021)
Elise Aasebø, Annette K Brenner, Maria Hernandez-Valladares, Even Birkeland, Frode S Berven, Frode Selheim, Øystein Bruserud
Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells. International journal of molecular sciences 22 (11) (2021)
Ida Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, Sushma Bartaula-Brevik, Maria Hernandez-Valladares, Frode Selheim, Frode S Berven, Tor Henrik Tvedt, Øystein Bruserud, Kimberley Joanne Hatfield
Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity. Journal of personalized medicine 11 (8) (2021)
Elise Aasebø, Annette K Brenner, Maria Hernandez-Valladares, Even Birkeland, Olav Mjaavatten, Håkon Reikvam, Frode Selheim, Frode S Berven, Øystein Bruserud
Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells. Diseases (Basel, Switzerland) 9 (4) (2021)
Elise Aasebø, Frode S Berven, Randi Hovland, Stein Ove Døskeland, Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares
The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles. Cancers 12 (6) (2020)
Ida Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, Sushma Bartaula-Brevik, Tor Henrik Tvedt, Øystein Bruserud, Kimberley Joanne Hatfield
Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity. Cells 9 (5) (2020)
Elise Aasebø, Even Birkeland, Frode Selheim, Frode Berven, Annette K Brenner, Øystein Bruserud
The Extracellular Bone Marrow Microenvironment-A Proteomic Comparison of Constitutive Protein Release by In Vitro Cultured Osteoblasts and Mesenchymal Stem Cells. Cancers 13 (1) (2020)
Elise Aasebø, Frode S Berven, Sushma Bartaula-Brevik, Tomasz Stokowy, Randi Hovland, Marc Vaudel, Stein Ove Døskeland, Emmet McCormack, Tanveer S Batth, Jesper V Olsen, Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares
Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia. Cancers 12 (3) (2020)
Annette K Brenner, Elise Aasebø, Maria Hernandez-Valladares, Frode Selheim, Frode Berven, Ida-Sofie Grønningsæter, Sushma Bartaula-Brevik, Øystein Bruserud
The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome. Cancers 11 (1) (2019)
Håkon Reikvam, Elise Aasebø, Annette K Brenner, Sushma Bartaula-Brevik, Ida Sofie Grønningsæter, Rakel Brendsdal Forthun, Randi Hovland, Øystein Bruserud
High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype. Journal of clinical medicine 8 (7) (2019)
Elise Aasebø, Maria Hernandez-Valladares, Frode Selheim, Frode S Berven, Annette K Brenner, Øystein Bruserud
Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators. Proteomes 7 (1) (2018)